European Commission approves Venclyxto-based combinations for adults with newly diagnosed acute myeloid leukaemia who are ineligible for intensive chemotherapy
With hypomethylating agents significantly improved complete response rates in certain adults with newly diagnosed acute myeloid leukaemiaIn the VIALE-A study,...